These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34857874)

  • 1. KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth.
    Shimoda M; Lyu Y; Wang KH; Kumar A; Miura H; Meckler JF; Davis RR; Chantarasrivong C; Izumiya C; Tepper CG; Nakajima KI; Tuscano J; Barisone G; Izumiya Y
    Commun Biol; 2021 Dec; 4(1):1330. PubMed ID: 34857874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
    Li X; Chen S; Feng J; Deng H; Sun R
    J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.
    Lee HR; Doğanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU
    J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
    Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
    J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300 promotes cell proliferation through suppressing Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation in the infected B-lymphoma cells.
    Sun C; Guo Y; Zhou W; Xia C; Xing X; Chen J; Li X; Zhu H; Lu J
    Virus Res; 2020 Sep; 286():198066. PubMed ID: 32553609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
    Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
    J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation.
    Gwack Y; Baek HJ; Nakamura H; Lee SH; Meisterernst M; Roeder RG; Jung JU
    Mol Cell Biol; 2003 Mar; 23(6):2055-67. PubMed ID: 12612078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
    Wei X; Bai L; Dong L; Liu H; Xing P; Zhou Z; Wu S; Lan K
    PLoS Pathog; 2019 Nov; 15(11):e1008160. PubMed ID: 31751430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.
    Nakamura H; Lu M; Gwack Y; Souvlis J; Zeichner SL; Jung JU
    J Virol; 2003 Apr; 77(7):4205-20. PubMed ID: 12634378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
    Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Bubman D; Guasparri I; Cesarman E
    Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P.
    Zhu J; Trang P; Kim K; Zhou T; Deng H; Liu F
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9073-8. PubMed ID: 15184661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.